The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 12, 2021

Filed:

Feb. 25, 2020
Applicant:

Vanda Pharmaceuticals Inc., Washington, DC (US);

Inventors:

Marlene Michelle Dressman, Germantown, MD (US);

Mihael H. Polymeropoulos, Potomac, MD (US);

Paolo Baroldi, Potomac, MD (US);

Assignee:

Vanda Pharmaceuticals Inc., Washington, DC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/343 (2006.01);
U.S. Cl.
CPC ...
A61K 31/343 (2013.01);
Abstract

One embodiment of the invention provides a method for administering tasimelteon to a human patient that comprises orally administering an effective dose of tasimelteon under fasted conditions. Fasted conditions may comprise administering the tasimelteon without food, no food at least ½ hour prior to administration, no food at least 1 hour prior to administration, no food at least 1½ hours prior to administration, no food at least 2 hours prior to administration, no food at least 2½ hours prior to administration, or no food at least 3 hours prior to administration. According to such embodiments, tasimelteon may be administered, for example, at a dose of 20 mg/d. Tasimelteon may be administered where, for example, the patient is being treated for a circadian rhythm disorder or for a sleep disorder, including, for example, Non-24 Disorder.


Find Patent Forward Citations

Loading…